企業プロフィール
Achilles Therapeutics 株価・ニュース・カタリスト
- ティッカー:
- ACHL
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United Kingdom
株価変動の要因
Current closing-price context is not available for ACHL.
企業概要
事業概要
Achilles Therapeutics was a T-cell and immunology company focused on precision cancer treatment before its restructuring and public-market decline. Its platform centered on clonal neoantigen targeting.
所在地とセクター分類
Headquartered in the United Kingdom and listed on NASDAQ as an ADR before restructuring, Achilles sat in oncology biotechnology.
ビジネスモデルの特徴
The company depended on clinical validation, platform science, and the ability to translate T-cell biology into value.
バイオ業界での位置付け
Achilles belongs to the historical cell-therapy and restructuring category rather than the current live set.
今後のカタリスト
- Achilles Therapeutics’s catalysts are its T-cell program and any update that clarifies whether the company can keep its solid-tumor platform alive. The stock still depends on human proof.
最近のニュース
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。